Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CellSource Co., Ltd. ( (JP:4880) ) has shared an update.
CellSource Co., Ltd. announced a dividend distribution despite a decline in net income due to changes in support agreements with medical institutions. The company aims to balance growth investments with stable shareholder returns, maintaining a dividend of 5.00 yen per share for the fiscal year ended October 31, 2025, exceeding their usual payout ratio.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen547.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
CellSource Co., Ltd. operates in the medical support services industry, focusing on providing support agreements with medical institutions. The company is listed on the Tokyo Stock Exchange, Prime Market, under the securities code 4880.
Average Trading Volume: 80,833
Technical Sentiment Signal: Sell
Current Market Cap: Yen8.62B
See more data about 4880 stock on TipRanks’ Stock Analysis page.